Here are four trends Komen is watching that are shaping the breast cancer research landscape in 2026 and beyond. Breast cancer research continues to advance with new clinical trial results, often leading to FDA approvals and new options for breast cancer diagnosis, testing and treatment. Komen monitors clinical trial results, FDA approvals and ongoing […]
Six years ago, Beth Porreca learned she had stage 4 inflammatory breast cancer (IBC). “I had no idea what IBC was,” Beth said. “I had a rash and some swelling. I honestly thought I was having an allergic reaction. I was wrong. I had more than a rash.” Watch Beth’s story in her own words.
Kendra Batchelder is the founder and CEO of Madera, a company focused on predicting cancer risk using artificial intelligence (AI). She holds a PhD in computational medicine focused on signal processing. She recently shared her insights on the way AI is transforming mammography with Susan G. Komen.
The 2026 Susan G. Komen Boston 3-Day® delivered an unforgettable weekend of impact. With more than 900 walkers and crew members, the event raised $2.3 million for breast cancer research, community health, patient care and advocacy. Our top fundraisers helped drive that momentum, inspiring the entire Pink Bubble with their dedication.
Krystina never imagined she would be diagnosed with breast cancer at 35. Discovering a small lump ultimately led to a diagnosis of triple negative breast cancer (TNBC) and the detection of an BRCA1 inherited gene mutation. As she navigated treatment, fertility decisions and the challenges of being a young woman with breast cancer, she found a community of survivors who helped her realize she wasn’t alone.
Breast cancer support has come in many forms for Amanda Crespo, from the care of her oncologist, Dr. Samina Ahmed, to the peer mentor who helped her navigate treatment. Now a peer mentor herself, Amanda will join Dr. Ahmed at the Komen Orange County Pink Tie Party, where Dr. Ahmed will be recognized for her commitment to the breast cancer community as a Pink Tie Partner.
At the 2026 Susan G. Komen Boston 3-Day®, Laura P. was honored with the Milestone Award, recognizing her extraordinary contributions to the Pink Bubble community.
After receiving the news she had breast cancer, Wendy DeWeerd faced her diagnosis head-on. In the midst of treatment, she’s stepping up to do more by sharing her breast cancer story and fundraising to help end breast cancer through her local Race for the Cure.
At last week’s Susan G. Komen Boston 3-Day®, Kristin S. was honored with the Crew Impact Award, celebrating her dedication to leading with heart, serving with purpose and lifting the spirits of everyone around her in the Pink Bubble.
After receiving a breast cancer diagnosis at 35, Sheila learned she had a BRCA2 inherited gene mutation and faced difficult decisions about surgery and reconstruction. Throughout her experience, she learned the importance of advocating for herself and choosing what was right for her.
As the use of artificial intelligence (AI) expands, scientists are exploring ways to integrate this technology into breast cancer research and improve breast cancer care. In this episode of Breast Cancer Breakthroughs, we speak with Komen Scholars, Nancy Lin, M.D. and Christina Curtis, Ph.D., along with Komen Metastatic Breast Cancer (MBC) Steering Committee member, Megan […]
This past weekend marked the season opener for the Susan G. Komen 3-Day®. More than 900 walkers and crew members filled the cobblestone streets of Boston, raising an inspiring $2.3 million to help end breast cancer.
